首页 | 本学科首页   官方微博 | 高级检索  
检索        

痰热清注射液治疗重型乙型肝炎合并全身炎症反应综合征疗效观察
引用本文:张浩晔,刘振国,龚健.痰热清注射液治疗重型乙型肝炎合并全身炎症反应综合征疗效观察[J].中国中医急症,2010,19(2):214-216.
作者姓名:张浩晔  刘振国  龚健
作者单位:中南大学湘雅三医院,长沙,410013
摘    要:目的观察痰热清注射液治疗重型乙型肝炎合并全身炎症反应综合征患者的临床疗效。方法将56例重型乙型肝炎合并全身炎症反应综合征患者随机分为两组,治疗组30例在常规护肝、抗感染等常规治疗的基础上给予痰热清注射液入液静滴,对照组26例仅予常规治疗,两组疗程均为10d;比较两组治疗后生命体征、生化指标、血清细胞因子水平等的变化及病情转归。结果治疗组在疗程结束后生命体征、生化指标、细胞因子水平均有明显改善,其改善程度优于对照组,部分并发症发生率低于对照组。结论痰热清注射液能抑制全身炎症反应综合征患者细胞因子表达,减轻炎症反应,减少并发症的发生,从而改善重型乙型肝炎的预后。

关 键 词:全身炎症反应综合征  重型乙型肝炎  痰热清注射液  细胞因子

Observation of Tanreqing Injection in Severe Hepatitis B merging Systemic Inflammatory Response Syndrone
ZHANG Hao-ye,LIU Zhen-guo,GONG jian.Observation of Tanreqing Injection in Severe Hepatitis B merging Systemic Inflammatory Response Syndrone[J].Journal of Emergency in Traditional Chinese Medicine,2010,19(2):214-216.
Authors:ZHANG Hao-ye  LIU Zhen-guo  GONG jian
Institution:ZHANG Hao-ye,LIU Zhen-guo,GONG jian The Third Xiangya Hospital of Central South University(Changsha410013)
Abstract:Objective:To observe the curative of Tanreqing injection in severe hepatitis B merging systemic inflammatory response syndrome(SIRS).Methods:56 patients with severe hepatitis B merging SIRS were divided randomly into two groups.30 patients in the treatment group were given Tanreqing injection besides normal protecting liver and anti-infection.The 26 patients in the control group were just given normal treatment.After 10 days for treating,the physical sign,the biochemical criterion and the level of cytokine ...
Keywords:Systemic inflammatory response syndroe(SIRS)  Severe hepatitis B  Tanreqing injection  Cytokine  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号